Clinical trials recruiting in Speyer, Germany

Phase breakdown

Conditions recruiting in Speyer, Germany

Recruiting trials in Speyer, Germany

• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
  NCT07503210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
  NCT05452213 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female
• Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
  NCT06380738 · Phase: Not specified · Ages: 18 Years and older · Sex: Male

Common questions

How many clinical trials are recruiting in Speyer, Germany?

4 recruiting trials have at least one study site in Speyer, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.